(en) Mosconi S, Beretta G.D, Labianca R, Zampino M.G, Gatta G & Heinemann V (2009). Cholangiocarcinoma. Critical reviews in oncology/hematology, 69(3), 259-270.
doi.org
dx.doi.org
Études indépendantes ayant observé une augmentation ininterrompue de l'incidence du cholangiocarcinome dans le monde :
(en) T. Patel, « Worldwide trends in mortality from biliary tract malignancies », BMC Cancer, vol. 2, , p. 10. (PMID11991810, DOI10.1186/1471-2407-2-10)
(en) A. Nakeeb, H. Pitt, T. Sohn, J. Coleman, R. Abrams,
S. Piantadosi, R. Hruban, K. Lillemoe, C. Yeo, J. Cameron, « Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors », Ann Surg, vol. 224, no 4, , p. 463–73 ; discussion 473–5. (PMID8857851, DOI10.1097/00000658-199610000-00005)
(en) S. Khan, S. Taylor-Robinson, M. Toledano, A. Beck, P. Elliott, H. Thomas, « Changing international trends in mortality rates for liver, biliary and pancreatic tumours », J Hepatol, vol. 37, no 6, , p. 806–13. (PMID12445422, DOI10.1016/S0168-8278(02)00297-0)
Études épidémiologiques portant sur l'incidence du cholangiocarcinome chez les personnes avec une cholangite sclérosante primitive :
(en) A. Bergquist, A. Ekbom, R. Olsson, D. Kornfeldt, U. Broomé et al., « Hepatic and extrahepatic malignancies in primary sclerosing cholangitis », J Hepatol, vol. 36, no 3, , p. 321–7. (PMID11867174, DOI10.1016/S0168-8278(01)00288-4)
(en) C. Rosen, D. Nagorney, R. Wiesner, R. Coffey, N. LaRusso, « Cholangiocarcinoma complicating primary sclerosing cholangitis », Ann Surg, vol. 213, no 1, , p. 21-5. (PMID1845927, DOI10.1097/00000658-199101000-00004)
(en) P. Watanapa, « Cholangiocarcinoma in patients with opisthorchiasis », Br J Surg, vol. 83, no 8, , p. 1062–64. (PMID8869303, DOI10.1002/bjs.1800830809)
(en) H. Shin, C. Lee, H. Park, S. Seol, J. Chung, H. Choi, Y. Ahn, T. Shigemastu, « Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea », Int J Epidemiol, vol. 25, no 5, , p. 933–40. (PMID8921477, DOI10.1093/ije/25.5.933)
(en) M. J. Smout, T. Laha, J. Mulvenna, B. Sripa, S. Suttiprapa, A. Jones, P. J. Brindley, A. Loukas, « A Granulin-Like Growth Factor Secreted by the Carcinogenic Liver Fluke, Opisthorchis viverrini, Promotes Proliferation of Host Cells », PLoS Pathogens, (DOI10.1371/journal.ppat.1000611, lire en ligne)
(en) M. Kobayashi, K. Ikeda, S. Saitoh, F. Suzuki, A. Tsubota, Y. Suzuki, Y. Arase, N. Murashima, K. Chayama, H. Kumada, « Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis », Cancer, vol. 88, no 11, , p. 2471-7. (PMID10861422, DOI10.1002/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T)
(en) S. Yamamoto, S. Kubo, S. Hai, T. Uenishi, T. Yamamoto, T. Shuto, S. Takemura, H. Tanaka, O. Yamazaki, K. Hirohashi, T. Tanaka, « Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma », Cancer Sci, vol. 95, no 7, , p. 592–5. (PMID15245596, DOI10.1111/j.1349-7006.2004.tb02492.x)
(en) H. Sorensen, S. Friis, J. Olsen, A. Thulstrup, L. Mellemkjaer, M. Linet, D. Trichopoulos, H. Vilstrup, J. Olsen, « Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark », Hepatology, vol. 28, no 4, , p. 921–5. (PMID9755226, DOI10.1002/hep.510280404)
(en) Y. Shaib, H. El-Serag, J. Davila, R. Morgan, K. McGlynn, « Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study », Gastroenterol, vol. 128, no 3, , p. 620–6. (PMID15765398, DOI10.1053/j.gastro.2004.12.048)
(en) P. Lipsett, H. Pitt, P. Colombani, J. Boitnott, J. Cameron, « Choledochal cyst disease. A changing pattern of presentation », Ann Surg, vol. 220, no 5, , p. 644–52. (PMID7979612, DOI10.1097/00000658-199411000-00007)
(en) M. Dayton, W. Longmire, R. Tompkins, « Caroli's Disease: a premalignant condition? », Am J Surg, vol. 145, no 1, , p. 41–8. (PMID6295196, DOI10.1016/0002-9610(83)90164-2)
(en) S. Lee, M. Kim, S. Jang, M. Song, K. Kim, H. Kim, D. Seo, D. Song, E. Yu, Y. Min, « Clinicopathologic review of 58 patients with biliary papillomatosis », Cancer, vol. 100, no 4, , p. 783–93. (PMID14770435, DOI10.1002/cncr.20031)
(en) C. Lee, C. Wu, G. Chen, « What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma? », J Gastroenterol Hepatol, vol. 17, no 9, , p. 1015–20. (PMID12167124, DOI10.1046/j.1440-1746.2002.02779.x)
(en) C. Su, Y. Shyr, W. Lui, F. P'Eng, « Hepatolithiasis associated with cholangiocarcinoma », Br J Surg, vol. 84, no 7, , p. 969–73. (PMID9240138, DOI10.1002/bjs.1800840717)
(en) F. Donato, U. Gelatti, A. Tagger, M. Favret, M. Ribero, F. Callea, C. Martelli, A. Savio, P. Trevisi, G. Nardi, « Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy », Cancer Causes Control, vol. 12, no 10, , p. 959–64. (PMID11808716, DOI10.1023/A:1013747228572)
(en) D. Sahani, S. Prasad, K. Tannabe, P. Hahn, P. Mueller, S. Saini, « Thorotrast-induced cholangiocarcinoma: case report », Abdom Imaging, vol. 28, no 1, , p. 72–4. (PMID12483389, DOI10.1007/s00261-001-0148-y)
(en) A. Zhu, G. Lauwers, K. Tanabe, « Cholangiocarcinoma in association with Thorotrast exposure », J Hepatobiliary Pancreat Surg, vol. 11, no 6, , p. 430–3. (PMID15619021, DOI10.1007/s00534-004-0924-5)
(en) T. Roskams, « Liver stem cells and their implication in hepatocellular and cholangiocarcinoma », Oncogene, vol. 25, no 27, , p. 3818–22. (PMID16799623, DOI10.1038/sj.onc.1209558)
(en) A. Sirica, « Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy », Hepatology, vol. 41, no 1, , p. 5–15. (PMID15690474, DOI10.1002/hep.20537)
(en) G. Gores, « Cholangiocarcinoma: current concepts and insights », Hepatology, vol. 37, no 5, , p. 961–9. (PMID12717374, DOI10.1053/jhep.2003.50200)
(en) C. J. Scarlett, A. J. Saxby, A. Q. Nielsen, C. Bell, J. S. Samra, T. Hugh, R. C. Baxter, R. C. Smith, « Proteomic profiling of cholangiocarcinoma: Diagnostic potential of SELDI-TOF MS in malignant bile duct structure », Hepatology, vol. 44, no 3, , p. 658-66. (DOI10.1002/hep.21294)
Études sur la performance des marqueurs sériques (tels l'antigène carcino-embryonnaire ou CA 19.9) dans le dépistage du cholangiocarcinome :
(en) D. Marrelli et al., « CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions », Am J Surg, vol. 198, no 3, , p. 333-9. (DOI10.1016/j.amjsurg.2008.12.031)
(en) C. Valls, A. Gumà, I. Puig, A. Sanchez, E. Andía, T. Serrano, J. Figueras, « Intrahepatic peripheral cholangiocarcinoma: CT evaluation », Abdom Imaging, vol. 25, no 5, , p. 490–6. (PMID10931983, DOI10.1007/s002610000079)
(en) Y. Zhang, M. Uchida, T. Abe, H. Nishimura, N. Hayabuchi, Y. Nakashima, « Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI », J Comput Assist Tomogr, vol. 23, no 5, , p. 670–7. (PMID10524843, DOI10.1097/00004728-199909000-00004)
(en) N. Akamatsu, Y. Sugawara et al., « Diagnostic accuracy of multidetector-row computed tomography for hilar cholangiocarcinoma », Hepatology, (DOI10.1111/j.1440-1746.2009.06113.x)
(en) M. Sugiyama, H. Hagi, Y. Atomi, M. Saito, « Diagnosis of portal venous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography », Abdom Imaging, vol. 22, no 4, , p. 434–8. (PMID9157867, DOI10.1007/s002619900227)
(en) S. Zidi, F. Prat, O. Le Guen, Y. Rondeau, G. Pelletier, « Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures », Gut, vol. 46, no 1, , p. 103–6. (PMID10601064, DOI10.1136/gut.46.1.103)
(en) M. Lee, K. Park, Y. Shin, H. Yoon, K. Sung, M. Kim, S. Lee, E. Kang, « Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography », World J Surg, vol. 27, no 3, , p. 278–83. (PMID12607051, DOI10.1007/s00268-002-6701-1)
(en) T. Yeh, Y. Jan, J. Tseng, C. Chiu, T. Chen, T. Hwang, M. Chen, « Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings », Am J Gastroenterol, vol. 95, no 2, , p. 432–40. (PMID10685746, DOI10.1111/j.1572-0241.2000.01763.x)
(en) J. Szklaruk, E. Tamm, C. Charnsangavej, « Preoperative imaging of biliary tract cancers », Surg Oncol Clin N Am, vol. 11, no 4, , p. 865–76. (PMID12607576, DOI10.1016/S1055-3207(02)00032-7)
(en) S. Weber, R. DeMatteo, Y. Fong, L. Blumgart, W. Jarnagin, « Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients », Ann Surg, vol. 235, no 3, , p. 392–9. (PMID11882761, DOI10.1097/00000658-200203000-00011)
Ramacciato G et al., « Facteurs pronostiques après résection pour cholangiocarcinome hilaire », Annales de Chirurgie, vol. 131, nos 6-7, , p. 379-85. (DOI10.1016/j.anchir.2006.03.006)
(de) F. Länger, R. von Wasielewski, H. H. Kreipe, « Bedeutung der Immunhistochemie für die Diagnose des Cholangiokarzinoms », Pathologie, vol. 27, no 4, , p. 244–50. (PMID16758167, DOI10.1007/s00292-006-0836-z)
(en) E. Patsenker, L. Wilkens, V. Banz, C.H. Österreicher, R. Weimann, S. Eisele, A. Keogh, D. Stroka, A. Zimmermann, F. Stickel, « The αvβ6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma », Journal of Hepatology, (DOI10.1016/j.jhep.2009.12.006)
(en) C. Su, S. Tsay, C. Wu, Y. Shyr, K. King, C. Lee, W. Lui, T. Liu, F. P'eng, « Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma », Ann Surg, vol. 223, no 4, , p. 384–94. (PMID8633917, DOI10.1097/00000658-199604000-00007)
(en) M. Ohtsuka, H. Ito, F. Kimura, H. Shimizu, A. Togawa, H. Yoshidome, Dr M. Miyazaki, « Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival », British Journal of Surgery, vol. 89, no 12, , p. 1521-1535 (DOI10.1046/j.1365-2168.2002.02268.x)
(en) Zhong Chen, Jianjun Yan, Liang Huang, Yiqun Yan, « Prognostic analysis of patients suffering from intrahepatic cholangiocarcinoma », The Chinese-German Journal of Clinical Oncology, vol. 10, no 3, , p. 150-152 (DOI10.1007/s10330-011-0738-2)
(en) H. Pitt, A. Nakeeb, R. Abrams, J. Coleman, S. Piantadosi, C. Yeo, K. Lillemore, J. Cameron, « Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival », Ann Surg, vol. 221, no 6, , p. 788–97; discussion 797–8 (PMID7794082, DOI10.1097/00000658-199506000-00017)
(en) T. Takada, H. Amano, H. Yasuda, Y. Nimura, T. Matsushiro, H. Kato, T. Nagakawa, T. Nakayama, « Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma », Cancer, vol. 95, no 8, , p. 1685–95 (PMID12365016, DOI10.1002/cncr.10831)
(en) C. Choi, I. Choi, J. Seo, B. Kim, J. Kim, C. Kim, S. Um, Y. Kim, « Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas », Am J Clin Oncol, vol. 23, no 4, , p. 425–8 (PMID10955877, DOI10.1097/00000421-200008000-00023)
(en) J. Park, S. Oh, S. Kim, H. Kwon, J. Kim, H. Jin-Kim, Y. Kim, « Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study », Jpn J Clin Oncol, vol. 35, no 2, , p. 68–73 (PMID15709089, DOI10.1093/jjco/hyi021)
(en) J. Knox, D. Hedley, A. Oza, R. Feld, L. Siu, E. Chen, M. Nematollahi, G. Pond, J. Zhang, M. Moore, « Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial », J Clin Oncol, vol. 23, no 10, , p. 2332–8 (PMID15800324, DOI10.1200/JCO.2005.51.008)
(en) P. Philip, M. Mahoney, C. Allmer, J. Thomas, H. Pitot, G. Kim, R. Donehower, T. Fitch, J. Picus, C. Erlichman, « Phase II study of erlotinib in patients with advanced biliary cancer », J Clin Oncol, vol. 24, no 19, , p. 3069–74 (PMID16809731, DOI10.1200/JCO.2005.05.3579)
(en) M. Yamamoto, K. Takasaki, T. Yoshikawa, « Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma », Japanese Journal of Clinical Oncology, vol. 29, no 3, , p. 147–150 (PMID10225697, DOI10.1093/jjco/29.3.147)
(en) D. Farley, A. Weaver, D. Nagorney, « « Natural history » of unresected cholangiocarcinoma: patient outcome after noncurative intervention », Mayo Clin Proc, vol. 70, no 5, , p. 425–9 (PMID7537346, DOI10.4065/70.5.425)
(en) M. K. Grove, R. E. Hermann, D. P. Vogt, T. A. Broughan, « Role of radiation after operative palliation in cancer of the proximal bile ducts », Am J Surg, vol. 161, , p. 454–458 (DOI10.1016/0002-9610(91)91111-U)
(en) E. Zervos, D. Osborne, S. Goldin, D. Villadolid, D. Thometz, A. Durkin, L. Carey, A. Rosemurgy, « Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach », Am J Surg, vol. 190, no 5, , p. 810–5 (PMID16226963, DOI10.1016/j.amjsurg.2005.07.025)
(en) J. Tsao, Y. Nimura, J. Kamiya, N. Hayakawa, S. Kondo, M. Nagino, M. Miyachi, M. Kanai, K. Uesaka, K. Oda, R. Rossi, J. Braasch, J. Dugan, « Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience », Ann Surg, vol. 232, no 2, , p. 166–74 (PMID10903592, DOI10.1097/00000658-200008000-00003)
L. Droy, C. Sagan, J. Paineau, J. Gournay, J. F. Mosnier, « Cholangiocarcinomes sur syndrome des microhamartomes biliaires multiples », Annales de pathologie, vol. 29, no 1, , p. 24-7. (PMID19233090, résumé)
(en) W. Kenneth Washburn, W. David Lewis, Roger L. Jenkins, « Aggressive Surgical Resection for Cholangiocarcinoma », Arch Surg, vol. 130, no 3, , p. 270-276 (ISSN0004-0010, PMID7534059)
Dr Hubert Claes, « Un traitement par irinotécan liposomal en deuxième ligne améliore la survie en cas de cancer métastatique des voies biliaires », Belgian oncology & hematology news, (lire en ligne, consulté le )
(en) Valle, Juan, Wasan, Harpreet, Palmer, H. Daniel, Cunningham, David, Anthoney, Alan, Maraveyas, Anthony, Madhusudan, Srinivasan, Iveson, Tim, Hughes, Sharon, Pereira, P. Stephen, Roughton, Michael, Bridgewater, John, the ABC-02 Trial Investigators,
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract CancerN Engl J Med 2010;362:1273-81.
nih.gov
ncbi.nlm.nih.gov
Études indépendantes ayant observé une augmentation ininterrompue de l'incidence du cholangiocarcinome dans le monde :
(en) T. Patel, « Worldwide trends in mortality from biliary tract malignancies », BMC Cancer, vol. 2, , p. 10. (PMID11991810, DOI10.1186/1471-2407-2-10)
(en) D. Nagorney, J. Donohue, M. Farnell, C. Schleck, D. Ilstrup, « Outcomes after curative resections of cholangiocarcinoma », Arch Surg, vol. 128, no 8, , p. 871–7 ; discussion 877–9. (PMID8393652)
(en) A. Nakeeb, H. Pitt, T. Sohn, J. Coleman, R. Abrams,
S. Piantadosi, R. Hruban, K. Lillemoe, C. Yeo, J. Cameron, « Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors », Ann Surg, vol. 224, no 4, , p. 463–73 ; discussion 473–5. (PMID8857851, DOI10.1097/00000658-199610000-00005)
(en) S. Khan, S. Taylor-Robinson, M. Toledano, A. Beck, P. Elliott, H. Thomas, « Changing international trends in mortality rates for liver, biliary and pancreatic tumours », J Hepatol, vol. 37, no 6, , p. 806–13. (PMID12445422, DOI10.1016/S0168-8278(02)00297-0)
(en) R. Chapman, « Risk factors for biliary tract carcinogenesis », Ann Oncol, vol. 10 Suppl 4, , p. 308–11. (PMID10436847)
Études épidémiologiques portant sur l'incidence du cholangiocarcinome chez les personnes avec une cholangite sclérosante primitive :
(en) A. Bergquist, A. Ekbom, R. Olsson, D. Kornfeldt, U. Broomé et al., « Hepatic and extrahepatic malignancies in primary sclerosing cholangitis », J Hepatol, vol. 36, no 3, , p. 321–7. (PMID11867174, DOI10.1016/S0168-8278(01)00288-4)
(en) C. Rosen, D. Nagorney, R. Wiesner, R. Coffey, N. LaRusso, « Cholangiocarcinoma complicating primary sclerosing cholangitis », Ann Surg, vol. 213, no 1, , p. 21-5. (PMID1845927, DOI10.1097/00000658-199101000-00004)
(en) P. Watanapa, « Cholangiocarcinoma in patients with opisthorchiasis », Br J Surg, vol. 83, no 8, , p. 1062–64. (PMID8869303, DOI10.1002/bjs.1800830809)
(en) H. Shin, C. Lee, H. Park, S. Seol, J. Chung, H. Choi, Y. Ahn, T. Shigemastu, « Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea », Int J Epidemiol, vol. 25, no 5, , p. 933–40. (PMID8921477, DOI10.1093/ije/25.5.933)
(en) M. J. Smout, T. Laha, J. Mulvenna, B. Sripa, S. Suttiprapa, A. Jones, P. J. Brindley, A. Loukas, « A Granulin-Like Growth Factor Secreted by the Carcinogenic Liver Fluke, Opisthorchis viverrini, Promotes Proliferation of Host Cells », PLoS Pathogens, (DOI10.1371/journal.ppat.1000611, lire en ligne)
(en) M. Kobayashi, K. Ikeda, S. Saitoh, F. Suzuki, A. Tsubota, Y. Suzuki, Y. Arase, N. Murashima, K. Chayama, H. Kumada, « Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis », Cancer, vol. 88, no 11, , p. 2471-7. (PMID10861422, DOI10.1002/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T)
(en) S. Yamamoto, S. Kubo, S. Hai, T. Uenishi, T. Yamamoto, T. Shuto, S. Takemura, H. Tanaka, O. Yamazaki, K. Hirohashi, T. Tanaka, « Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma », Cancer Sci, vol. 95, no 7, , p. 592–5. (PMID15245596, DOI10.1111/j.1349-7006.2004.tb02492.x)
(en) H. Lu, M. Ye, S. Thung, S. Dash, M. Gerber, « Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients », Chin Med J (Engl), vol. 113, no 12, , p. 1138–41. (PMID11776153)
(en) H. Sorensen, S. Friis, J. Olsen, A. Thulstrup, L. Mellemkjaer, M. Linet, D. Trichopoulos, H. Vilstrup, J. Olsen, « Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark », Hepatology, vol. 28, no 4, , p. 921–5. (PMID9755226, DOI10.1002/hep.510280404)
(en) Y. Shaib, H. El-Serag, J. Davila, R. Morgan, K. McGlynn, « Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study », Gastroenterol, vol. 128, no 3, , p. 620–6. (PMID15765398, DOI10.1053/j.gastro.2004.12.048)
(en) P. Lipsett, H. Pitt, P. Colombani, J. Boitnott, J. Cameron, « Choledochal cyst disease. A changing pattern of presentation », Ann Surg, vol. 220, no 5, , p. 644–52. (PMID7979612, DOI10.1097/00000658-199411000-00007)
(en) M. Dayton, W. Longmire, R. Tompkins, « Caroli's Disease: a premalignant condition? », Am J Surg, vol. 145, no 1, , p. 41–8. (PMID6295196, DOI10.1016/0002-9610(83)90164-2)
L. Droy, C. Sagan, J. Paineau, J. Gournay, J. F. Mosnier, « Cholangiocarcinomes sur syndrome des microhamartomes biliaires multiples », Annales de pathologie, vol. 29, no 1, , p. 24-7. (PMID19233090, résumé)
(en) J. Mecklin, H. Järvinen, M. Virolainen, « The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma », Cancer, vol. 69, no 5, , p. 1112–4. (PMID1310886)
(en) S. Lee, M. Kim, S. Jang, M. Song, K. Kim, H. Kim, D. Seo, D. Song, E. Yu, Y. Min, « Clinicopathologic review of 58 patients with biliary papillomatosis », Cancer, vol. 100, no 4, , p. 783–93. (PMID14770435, DOI10.1002/cncr.20031)
(en) C. Lee, C. Wu, G. Chen, « What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma? », J Gastroenterol Hepatol, vol. 17, no 9, , p. 1015–20. (PMID12167124, DOI10.1046/j.1440-1746.2002.02779.x)
(en) C. Su, Y. Shyr, W. Lui, F. P'Eng, « Hepatolithiasis associated with cholangiocarcinoma », Br J Surg, vol. 84, no 7, , p. 969–73. (PMID9240138, DOI10.1002/bjs.1800840717)
(en) F. Donato, U. Gelatti, A. Tagger, M. Favret, M. Ribero, F. Callea, C. Martelli, A. Savio, P. Trevisi, G. Nardi, « Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy », Cancer Causes Control, vol. 12, no 10, , p. 959–64. (PMID11808716, DOI10.1023/A:1013747228572)
(en) D. Sahani, S. Prasad, K. Tannabe, P. Hahn, P. Mueller, S. Saini, « Thorotrast-induced cholangiocarcinoma: case report », Abdom Imaging, vol. 28, no 1, , p. 72–4. (PMID12483389, DOI10.1007/s00261-001-0148-y)
(en) A. Zhu, G. Lauwers, K. Tanabe, « Cholangiocarcinoma in association with Thorotrast exposure », J Hepatobiliary Pancreat Surg, vol. 11, no 6, , p. 430–3. (PMID15619021, DOI10.1007/s00534-004-0924-5)
(en) T. Roskams, « Liver stem cells and their implication in hepatocellular and cholangiocarcinoma », Oncogene, vol. 25, no 27, , p. 3818–22. (PMID16799623, DOI10.1038/sj.onc.1209558)
(en) C. Liu, J. Wang, Q. Ou, « Possible stem cell origin of human cholangiocarcinoma », World J Gastroenterol, vol. 10, no 22, , p. 3374–6. (PMID15484322)
(en) S. Sell, H. Dunsford, « Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma », American Journal of Pathology, vol. 134, no 6, , p. 1347–63. (PMID2474256)
(en) A. Sirica, « Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy », Hepatology, vol. 41, no 1, , p. 5–15. (PMID15690474, DOI10.1002/hep.20537)
(en) F. Holzinger, K. Z'graggen, M. Büchler, « Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma », Ann Oncol, vol. 10 Suppl 4, , p. 122–6. (PMID10436802)
(en) G. Gores, « Cholangiocarcinoma: current concepts and insights », Hepatology, vol. 37, no 5, , p. 961–9. (PMID12717374, DOI10.1053/jhep.2003.50200)
(en) M. Sharma, V. Ahuja, « Aetiological spectrum of obstructive jaundice and diagnostic ability of ultrasonography: a clinician's perspective », Trop Gastroenterol, vol. 20, no 4, , p. 167–9. (PMID10769604)
(en) C. Bloom, B. Langer, S. Wilson, « Role of US in the detection, characterization, and staging of cholangiocarcinoma », Radiographics, vol. 19, no 5, , p. 1199–218. (PMID10489176)
(en) C. Valls, A. Gumà, I. Puig, A. Sanchez, E. Andía, T. Serrano, J. Figueras, « Intrahepatic peripheral cholangiocarcinoma: CT evaluation », Abdom Imaging, vol. 25, no 5, , p. 490–6. (PMID10931983, DOI10.1007/s002610000079)
(en) M. Tillich, H. Mischinger, K. Preisegger, H. Rabl, D. Szolar, « Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma », AJR Am J Roentgenol, vol. 171, no 3, , p. 651–8. (PMID9725291)
(en) Y. Zhang, M. Uchida, T. Abe, H. Nishimura, N. Hayabuchi, Y. Nakashima, « Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI », J Comput Assist Tomogr, vol. 23, no 5, , p. 670–7. (PMID10524843, DOI10.1097/00004728-199909000-00004)
(en) M. Sugiyama, H. Hagi, Y. Atomi, M. Saito, « Diagnosis of portal venous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography », Abdom Imaging, vol. 22, no 4, , p. 434–8. (PMID9157867, DOI10.1007/s002619900227)
(en) L. Schwartz, F. Coakley, Y. Sun, L. Blumgart, Y. Fong, D. Panicek, « Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography », AJR Am J Roentgenol, vol. 170, no 6, , p. 1491–5. (PMID9609160)
(en) S. Zidi, F. Prat, O. Le Guen, Y. Rondeau, G. Pelletier, « Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures », Gut, vol. 46, no 1, , p. 103–6. (PMID10601064, DOI10.1136/gut.46.1.103)
(en) M. Lee, K. Park, Y. Shin, H. Yoon, K. Sung, M. Kim, S. Lee, E. Kang, « Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography », World J Surg, vol. 27, no 3, , p. 278–83. (PMID12607051, DOI10.1007/s00268-002-6701-1)
(en) T. Yeh, Y. Jan, J. Tseng, C. Chiu, T. Chen, T. Hwang, M. Chen, « Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings », Am J Gastroenterol, vol. 95, no 2, , p. 432–40. (PMID10685746, DOI10.1111/j.1572-0241.2000.01763.x)
(en) M. Freeman, T. Sielaff, « A modern approach to malignant hilar biliary obstruction », Rev Gastroenterol Disord, vol. 3, no 4, , p. 187–201. (PMID14668691)
(en) J. Szklaruk, E. Tamm, C. Charnsangavej, « Preoperative imaging of biliary tract cancers », Surg Oncol Clin N Am, vol. 11, no 4, , p. 865–76. (PMID12607576, DOI10.1016/S1055-3207(02)00032-7)
(en) S. Weber, R. DeMatteo, Y. Fong, L. Blumgart, W. Jarnagin, « Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients », Ann Surg, vol. 235, no 3, , p. 392–9. (PMID11882761, DOI10.1097/00000658-200203000-00011)
(en) M. Callery, S. Strasberg, G. Doherty, N. Soper, J. Norton, « Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancy », J Am Coll Surg, vol. 185, no 1, , p. 33–9. (PMID9208958)
(de) F. Länger, R. von Wasielewski, H. H. Kreipe, « Bedeutung der Immunhistochemie für die Diagnose des Cholangiokarzinoms », Pathologie, vol. 27, no 4, , p. 244–50. (PMID16758167, DOI10.1007/s00292-006-0836-z)
(en) C. Su, S. Tsay, C. Wu, Y. Shyr, K. King, C. Lee, W. Lui, T. Liu, F. P'eng, « Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma », Ann Surg, vol. 223, no 4, , p. 384–94. (PMID8633917, DOI10.1097/00000658-199604000-00007)
(en) W. Kenneth Washburn, W. David Lewis, Roger L. Jenkins, « Aggressive Surgical Resection for Cholangiocarcinoma », Arch Surg, vol. 130, no 3, , p. 270-276 (ISSN0004-0010, PMID7534059)
(en) T. Todoroki, K. Ohara, T. Kawamoto, N. Koike, S. Yoshida, H. Kashiwagi, M. Otsuka, K. Fukao, « Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma », Int J Radiat Oncol Biol Phys, vol. 46, no 3, , p. 581–7 (PMID10701737)
(en) M. Alden, M. Mohiuddin, « The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer », Int J Radiat Oncol Biol Phys, vol. 28, no 4, , p. 945–51 (PMID8138448)
(en) D. González, D. Gouma, E. Rauws, T. van Gulik, A. Bosma, C. Koedooder, « Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma », Ann Oncol, vol. 10 Suppl 4, , p. 215–20 (PMID10436826)
(en) H. Pitt, A. Nakeeb, R. Abrams, J. Coleman, S. Piantadosi, C. Yeo, K. Lillemore, J. Cameron, « Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival », Ann Surg, vol. 221, no 6, , p. 788–97; discussion 797–8 (PMID7794082, DOI10.1097/00000658-199506000-00017)
(en) T. Takada, H. Amano, H. Yasuda, Y. Nimura, T. Matsushiro, H. Kato, T. Nagakawa, T. Nakayama, « Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma », Cancer, vol. 95, no 8, , p. 1685–95 (PMID12365016, DOI10.1002/cncr.10831)
(en) B. Glimelius, K. Hoffman, P. Sjödén, G. Jacobsson, H. Sellström, L. Enander, T. Linné, C. Svensson, « Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer », Ann Oncol, vol. 7, no 6, , p. 593–600 (PMID8879373)
(en) C. Choi, I. Choi, J. Seo, B. Kim, J. Kim, C. Kim, S. Um, Y. Kim, « Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas », Am J Clin Oncol, vol. 23, no 4, , p. 425–8 (PMID10955877, DOI10.1097/00000421-200008000-00023)
(en) J. Park, S. Oh, S. Kim, H. Kwon, J. Kim, H. Jin-Kim, Y. Kim, « Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study », Jpn J Clin Oncol, vol. 35, no 2, , p. 68–73 (PMID15709089, DOI10.1093/jjco/hyi021)
(en) F. Giuliani, V. Gebbia, E. Maiello, N. Borsellino, E. Bajardi, G. Colucci, « Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM) », Ann Oncol, vol. 17 Suppl 7, , vii73-vii77 (PMID16760299)
(en) P. Bhargava, C. Jani, D. Savarese, J. O'Donnell, K. Stuart, C. Rocha Lima, « Gemcitabine and irinotecan in locally advanced or metastatic biliary cancer: preliminary report », Oncology (Williston Park), vol. 17, no 9 Suppl 8, , p. 23–6 (PMID14569844)
(en) J. Knox, D. Hedley, A. Oza, R. Feld, L. Siu, E. Chen, M. Nematollahi, G. Pond, J. Zhang, M. Moore, « Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial », J Clin Oncol, vol. 23, no 10, , p. 2332–8 (PMID15800324, DOI10.1200/JCO.2005.51.008)
(en) P. Philip, M. Mahoney, C. Allmer, J. Thomas, H. Pitot, G. Kim, R. Donehower, T. Fitch, J. Picus, C. Erlichman, « Phase II study of erlotinib in patients with advanced biliary cancer », J Clin Oncol, vol. 24, no 19, , p. 3069–74 (PMID16809731, DOI10.1200/JCO.2005.05.3579)
(en) M. Yamamoto, K. Takasaki, T. Yoshikawa, « Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma », Japanese Journal of Clinical Oncology, vol. 29, no 3, , p. 147–150 (PMID10225697, DOI10.1093/jjco/29.3.147)
(en) D. Farley, A. Weaver, D. Nagorney, « « Natural history » of unresected cholangiocarcinoma: patient outcome after noncurative intervention », Mayo Clin Proc, vol. 70, no 5, , p. 425–9 (PMID7537346, DOI10.4065/70.5.425)
(en) E. Zervos, D. Osborne, S. Goldin, D. Villadolid, D. Thometz, A. Durkin, L. Carey, A. Rosemurgy, « Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach », Am J Surg, vol. 190, no 5, , p. 810–5 (PMID16226963, DOI10.1016/j.amjsurg.2005.07.025)
(en) J. Tsao, Y. Nimura, J. Kamiya, N. Hayakawa, S. Kondo, M. Nagino, M. Miyachi, M. Kanai, K. Uesaka, K. Oda, R. Rossi, J. Braasch, J. Dugan, « Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience », Ann Surg, vol. 232, no 2, , p. 166–74 (PMID10903592, DOI10.1097/00000658-200008000-00003)
(en) V. Rajagopalan, W. Daines, M. Grossbard, P. Kozuch, « Gallbladder and biliary tract carcinoma: A comprehensive update, Part 1 », Oncology (Williston Park), vol. 18, no 7, , p. 889–96 (PMID15255172)
(en) Szendröi, M., Németh, L., & Vajta, G. (1983). Asbestos bodies in a bile duct cancer after occupational exposure. Environmental research, 30(2), 270-280|résumé.
(en) Frumkin H & Berlin J (1988). Asbestos Exposure and Gastrointestinal Malignancy Review and Meta‐Analysis. American journal of industrial medicine, 14(1), 79-95|résumé.